Interestingly, soluble VEGF levels decreased in adult ARDS patients in the first three days of VV-ECMO support [17], and in critically ill newborns on ECMO support [26], compared to patients without ECMO support. The gene discussed is VEGFA; the disease is acute respiratory distress syndrome.